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ABSTRACT
Long QT syndrome (LQTS) is characterized by a prolonged QT-
interval on electrocardiogram and by increased risk of sudden death.
One of the most common and potentially life-threatening electrolyte
disturbances is hypokalemia, characterized by low concentrations of
K+. Using a multielectrode array platform and current clamp
technique, we investigated the effect of low extracellular K+
concentration ([K+]Ex) on the electrophysiological properties of
hiPSC-derived cardiomyocytes (CMs) generated from a healthy
control subject (WT) and from two symptomatic patients with type 1 of
LQTS carrying G589D (LQT1A) or IVS7-2A>G mutation (LQT1B) in
KCNQ1. The baseline prolongations of field potential durations
(FPDs) and action potential durations (APDs) were longer in LQT1-
CMs than in WT-CMs. Exposure to low [K+]Ex prolonged FPDs and
APDs in a concentration-dependent fashion. LQT1-CMs were found
to be more sensitive to low [K+]Ex compared to WT-CMs. At baseline,
LQT1A-CMs had more prolonged APDs than LQT1B-CMs, but low
[K+]Ex caused more pronounced APD prolongation in LQT1B-CMs.
Early afterdepolarizations in the action potentials were observed in a
subset of LQT1A-CMs with further prolonged baseline APDs and
triangular phase 2 profiles. This work demonstrates that the hiPSC-
derivedCMs are sensitive to low [K+]Ex and provide a platform to study
acquired LQTS.
KEY WORDS: Induced pluripotent stem cells, Long QT syndrome,
Hypokalemia, Patch clamp, Multielectrode array
INTRODUCTION
Long QT syndrome (LQTS) presents as an acquired or inherited
arrhythmic disease characterized by prolonged QT interval on
electrocardiogram and is associated with the occurrence of syncope
or cardiac arrest. A special type of ventricular tachycardia known as
torsades de pointes may arise in LQTS, which may degenerate into
life-threatening ventricular fibrillation and cause sudden cardiac
death (Schwartz et al., 2013).
Congenital forms of LQTS typically result from mutations in the
cardiac ion channel-encoding genes. LQTS can be divided into
different subtypes with LQT1 being the most common subtype
caused by mutations in the KCNQ1. The KCNQ1 encodes the α-
subunit of the voltage-gated potassium channel and, assembled with
auxiliary β-subunits encoded byKCNE1, conducts the slow delayed
rectifier outward K+ current (IKs) (Barhanin et al., 1996; Sanguinetti
et al., 1996). The high prevalence (0.4%) of LQTS in Finland has
been explained by four founder mutations in the Finnish population
(Marjamaa et al., 2009). The most prevalent LQT1 causing founder
mutations is the C-terminal KCNQ1 G589D missense mutation
(Piippo et al., 2001). Evidence suggests that G589D is a moderate
dominant-negative traffickingmutation with normal functioning but
with hindered transport to the cell membrane (Aromolaran et al.,
2014). Another prevalent founder mutation is a strong dominant-
negative splice site mutation IVS7-2A>G (Fodstad et al., 2006).
Both, the G589D and IVS7-2A>G mutation types result in reduced
IKs current when co-expressed independently with wild-type
KCNQ1 and KCNE1 (Piippo et al., 2001; Fodstad et al., 2006).
Hypokalemia is one of the most common electrolyte disturbances
and is characterized by low blood serum K+ levels. In normokalemic
conditions, K+ concentrations range from 3.5-5.3 mM (Macdonald
and Struthers, 2004). In moderate hypokalemia, the K+
concentrations range from 2.5-3.0 mM; and in severe hypokalemia
they are <2.5 mM (Unwin et al., 2011). Hypokalemia is known to
delay ventricular repolarization, slow ventricular conduction, cause
hyperpolarization of the resting potential in ventricular myocytes as
well as cause abnormal ventricular automaticity increasing the risk of
ventricular arrhythmia and sudden cardiac death (Macdonald and
Struthers, 2004; Osadchii, 2010; Schulman and Narins, 1990).
About 40% of the patients on thiazide diuretics have been
reported to suffer from hypokalemia (Gennari, 1998) and a tenfold
increase in hospital mortality was found in hypokalemic patients
(Paltiel et al., 2001). Potassium electrolyte disturbance in serum is
recognized as a risk factor among LQTS patients. The mortality rate
of hospitalized hypokalemic patients was tenfold higher than in
generalized hospital population illustrating the potentially life-
threatening consequences of hypokalemia (Paltiel et al., 2001).
Other studies on hypokalemia have reported prolonged QT-
intervals, torsades de pointes and ventricular arrhythmias in
LQT1 patients (Schulman and Narins, 1990; Roden, 1997).
Under hypokalemic conditions, LQTS patients may be more
susceptible to exaggerated QT-interval prolongation than healthy
subjects because the repolarization reserve in LQTS patients is
already compromised due to mutation(s) in the cardiac ion channel
genes (Roden, 2004; Varró and Baczkó, 2011).
It is now possible to generate pluripotent stem cells (human
induced pluripotent stem cells; hiPSCs) from any individual
(Takahashi et al., 2007; Yu et al., 2007). hiPSCs have been
shown to be a feasible research tool for the study of inherited cardiac
diseases (e.g. LQTS) (Bellin et al., 2013; Moretti et al., 2010;
Itzhaki et al., 2011; Lahti et al., 2012; Egashira et al., 2012; MatsaReceived 12 January 2017; Accepted 11 April 2017
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et al., 2011; Spencer et al., 2014; Malan et al., 2011; Yazawa et al.,
2011; Ma et al., 2013; Kiviaho et al., 2015). The effects of low
extracellular K+ concentrations ([K+]Ex) have currently not been
investigated in hiPSC-derived LQT cardiomyocytes (CMs).
In this study, we have utilized a hiPSC-based model (Kiviaho
et al., 2015) to study the effects of low [K+]Ex in control CMs a well
as in LQT1-specific CMs carrying Finnish founder mutations
G589D or IVS7-2A>G. The electrophysiological properties of
control subject (WT), and LQT1A (carrying G589D), LQT1B
(carrying IVS7-2A>G) lines were assessed by determining the field
potential durations (FPDs) and action potential durations (APDs),
which correspond to surrogates for the QT-interval of the heart. The
prolongation of APDs, FPDs and early afterdepolarizations (EADs)
were assessed with low [K+]Ex using ventricular-like CMs fromWT,
LQT1A and LQT1B lines.
RESULTS
Effect of [K+]Ex on beating cardiomyocyte clusters
Baseline electrophysiological properties of healthy control (WT)
and patient-specific LQT1A and LQT1B CM clusters were assessed
by multielectrode array (MEA) measurements at 5.33 mM
extracellular K+ ([K+]Ex). Representative field potential traces
from baseline (upper panels) of WT, LQT1A and LQT1B,
respectively are depicted in Fig. 1A-C. Table 1A-C shows the
FPD and corrected field potential durations (cFPDs) using two
different correction formulae; Bazett and Fridericia. The
Fridericia’s correction formula was used to describe the extracted
MEA data and a comparison of baseline properties revealed that
cFPDs of LQT1A and LQT1B were more prolonged compared to
WT (P=1.8E-4, one-way ANOVA) and in the same test no
difference in cFPDs between LQT1A and LQT1B were found
(P=0.839, one-way ANOVA).
Following the investigation of baseline properties on the CM
clusters, the effect of sequential reduction to 3, 2 and 1 mM [K+]Ex
were studied. Representative field potential traces from 1 mM
[K+]Ex (lower panels) of WT, LQT1A and LQT1B, respectively are
depicted in Fig. 1A-C. A concentration-dependent increase in cFPD
correlated with sequential reduction in [K+]Ex (Table 1A-C).
Table 1A shows that low [K+]Ex prolonged cFPD in WT with
significant difference (P=0.045, paired t-test) at 1 mM [K+]Ex.
In contrast, the cFPD was significantly prolonged in LQT1A
(P=0.049, paired t-test) and LQT1B lines (P=0.043, paired t-test)
already at 3 mM [K+]ex (Table 1B,C). The absolute cFPD
prolongation in response to lowered [K+]Ex was calculated
(Table 1D) but no statistically significant differences were found
between the lines.
Effect of [K+]Ex on single beating cardiomyocytes
Similar to MEA, the electrophysiological properties of single CMs
were compared among WT, LQT1A and LQT1B in current clamp.
Table 2A-C shows extracted data from action potentials (AP)
consisting of: action potential duration (APD), action potential
amplitude (APA) and maximum diastolic potential (MDP). APD90/50
ratios were <1.30 indicating ventricular-like CM. The baseline APDs
of LQT1A and LQT1Bwere significantly longer thanWT (P<0.008,
one-way ANOVA) and in the same test the APDs showed that
LQT1A was significantly longer than LQT1B (P=0.007, n=22 in
each group, one-way ANOVA). The baseline APD50/10 ratio was
higher in LQT1A compared to WT and LQT1B, which indicates that
phase 2 of the APs in LQT1A were significantly more triangular in
shape (ratios: LQT1A2.95±0.13**,P<0.002: LQT1B2.45±0.09 and
WT 2.28±0.07, P=0.438, one-way ANOVA, n=22, Table 2A-C).
The [K+]Ex in the perfusate was then lowered from 4.8 mM at
baseline to 3, 2 or 1 mM and the effects were studied on the WT,
LQT1A and LQT1B CMs. The APDs and APAs were increased and
MDPs decreased at low [K+]Ex (Table 2A-C). Fig. 2A-C show
representative traces of baseline (upper trace) and 1 mM [K+]Ex
(lower trace). The relative prolongation of APD90 with low [K
+]Ex is
shown in Fig. 2D and the APD90 of LQT1B CMs were found to be
more prolonged compared to the LQT1A and WT CMs at 1 mM
[K+]Ex (P=0.025, one-way ANOVA). The absolute APD90
prolongation in response to lowered [K+]Ex was calculated in the
same data sets and is presented in Table 2D. This data reveals a more
Fig. 1. Representative traces of field potentials at baseline and at 1 mM
[K+]Ex in cardiomyocyte clusters and the dose-dependent prolongation in
field potentials corresponding to [K+]Ex. (A) Recording of a representative
field potential event by MEA at WT baseline (upper trace) and its
corresponding field potential event in the presence of 1 mM [K+]Ex (lower
trace). (B) and (C) are equivalent to (A), but show LQT1A (B) and LQT1B (C),
respectively. Scale bars: 40 µV (A), 10 µV (B) 10 µV in abscissa, (C) and the
ordinate is 100 ms. Dashed lines (A-C) indicate 0 µV. Arrows indicate the
endpoint of FPD.
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pronounced absolute APD90 prolongations with 1 mM in LQT1A
and LQT1B lines compared to WT. This suggests that LQT1A is
more prolonged in absolute terms while LQT1B is more sensitive to
low [K+]Ex in relative terms.
Single LQT1A cardiomyocytes exhibit arrhythmia
Low [K+]Ex did not evoke arrhythmias in WT, LQT1A and
LQT1B CM clusters in MEA recordings. Similarly, in current
clamp recordings no arrhythmias were found in WT and
LQT1B. However, LQT1A exhibited characteristics shown in
Fig. 3A,B. The APDs were further prolonged and exhibited early
afterdepolarizations (EADs) evoked only with 1 mM [K+]Ex
(Table 3A). In some LQT1As, EADs were already present in
baseline conditions (Table 3B). The total occurrence of LQT1A
CMs exhibiting EADs was 37.5%. In baselines without EADs (but
with EADs at low [K+]Ex), the APD90/50 were similar (<1.30) to
CMs without EADs at low [K+]Ex. However, in the former (EADs at
low [K+]Ex) the baseline APD50/10 ratios were higher than in the
latter (CMs without the EADs) (P=1.3E-6, unpaired t-test, APD50/10
ratio: 4.83±0.68 Table 3A and 2.95±0.13 Table 2B, see also Figs 2B
and 3A). Note, the CMs analyzed in Table 3A exhibited EADs only
with 1 mM [K+]Ex. CMs with EADs occurring at baseline had an
increase in EADs and APD prolongation with lower [K+]Ex
(Table 3B, Fig. 3B, arrows). The EAD ‘take off’ in baselines or
with 1 mM [K+]Ex occurred solely in phase 2 and were found to
range from −15 mV to −27 mV. EAD ‘take off’ in baselines were
−17.8±1.7 mV (n=5) and when evoked with 1 mM [K+]Ex −20.3±
1.3 mV (n=7), suggesting a role of L-type calcium current due to the
fact that the triangular phase 2 is driven towards more negative
membrane potential during further APD prolongation in these
LQT1A CMs.
DISCUSSION
This study demonstrates the effect of low [K+]Ex on WT, LQT1A
and LQT1B CMs using MEA and current clamp. The baseline
APD and FPD of LQT1A and LQT1B CMs were longer compared
to WT. Prolonged repolarization was evoked in a concentration-
dependent fashion by low [K+]Ex in all types of CMs with the
LQT1B CMs being most sensitive to low [K+]Ex. In current clamp
we found that MDP was decreased (hyperpolarized) and APA was
higher with low [K+]Ex. EADs were occasionally observed in
LQT1A at single cell level and these CMs had further prolonged
APDs already at baseline compared to the majority of LQT1A
CMs. An interesting finding was that the phase 2 triangularity
(APD50/10 ratio) was more pronounced in the LQT1A CMs at
baseline when EADs were present. In support of our data, previous
current clamp characteristics recorded at physiological potassium
conditions at baseline are similar to WT, LQT1A and LQT1B
CMs described in this study (Kiviaho et al., 2015). This is the first
study where low potassium concentration induces prolonged
repolarization in hiPSC-derived WT and LQTS CMs.
Additionally, EADs were observed only in CMs with G589D
Table 1. Field potential durations from cardiomyocyte clusters at baselines and low [K+]Ex
(A)
WT n FPD (ms) cFPD (Bazett) (ms) cFPD (Fridericia) (ms)
Baseline 3 334.72±19.65 377.48±11.34 362.57±14.27
3 mM K+ 358.42±28.64 407.56±19.33 390.37±22.62
Baseline 3 374,20±57.50 369.02±29.53 370.18±37.76
2 mM K+ 450.23±68.03* 414.81±54.13 426.13±57.95
Baseline 3 431.63±40.56 401.78±10.21 411.03±20.06
1 mM K+ 551.88±49.56* 463.57±20.11 484.30±20.72*
(B)
LQT1A n FPD (ms) cFPD (Bazett) (ms) cFPD (Fridericia) (ms)
Baseline 4 537.67±36.75 604.49±19.81 580.79±24.04
3mM K+ 604.52±17.70 644.68±19.95*** 630.47±12.02*
Baseline 5 520.96±34.91 565.97±27.62 549.81±27.27
2mM K+ 642.55±45.32 651.83±21.61* 647.70±26.51*
Baseline 4 539.81±19.78 596.36±28.18 576.30±21.06
1mM K+ 694.54±27.39* 720.79±5.84* 703.50±9.28*
(C)
LQT1B n FPD (ms) cFPD (Bazett) (ms) cFPD (Fridericia) (ms)
Baseline 5 515.04±26.59 549.79±31.79 537.56±27.90
3 mM K+ 596.29±23.59 664.03±21.52* 640.16±18.81*
Baseline 5 510.08±23.39 542.23±31.31 530.84±26.20
2 mM K+ 631.18±26.75* 684.68±17.52* 665.51±14.07*
Baseline 4 513.71±34.28 527.17±28.84 522.58±30.38
1 mM K+ 723.26±22.90* 716.31±22.11* 718.07±15.67*
(D)
K+ concentration n WT (ms) LQT1A (ms) LQT1B (ms)
3 mM 3/4/5 27.80±14.80 49.68±15.45 103.00±35.13
2 mM 3/5/5 55.93±21.53 97.88±28.35 134.67±33.56
1 mM 3/4/4 73.27±16.07 127.20±23.76 195.49±42.91
(A-C) FPDs and cFPDs at baseline and low [K+]Ex obtained from cardiomyocyte clusters on MEA for (A) WT, (B) LQT1A and (C) LQT1B, respectively. (D) The
absolute Δ increase in the FPDs in milliseconds from baseline to its corresponding 3, 2 and 1 mM [K+]Ex. Statistical significance in (A-C) was calculated by using
paired t-test, and in (D) it was calculated using ANOVA between the lines at each [K+]Ex *P<0.05, **P<0.01 and ***P<0.001. n=clusters recorded for each data
point. Data is presented as mean±s.e.m.
779
RESEARCH ARTICLE Biology Open (2017) 6, 777-784 doi:10.1242/bio.024216
B
io
lo
g
y
O
p
en
point mutation (LQT1A), but not in those carrying the IVS7-
2A>G mutations (LQT1B).
The appearance of EADs has been linked to the hyperpolarization
of cell membrane in low [K+]Ex conditions (Zaza, 2009). In the
present study, we show that EADs similarly emerge from more
hyperpolarized MDPs at low [K+]Ex. This is supported by an altered
K+ conductance and electromotive force during acute and chronic
low [K+]Ex and is further strengthened by similar findings with data
from animal ventricular cardiomyocytes (White and Terrar, 1991;
Ruiz Ceretti et al., 1982; Kishida et al., 1979; Zaza, 2009), in
transgenic rabbit LQT1 and LQT2 models (Liu et al., 2012) and in
transgenic mouse LQT2 model (Teng et al., 2004). Our data with
hiPSC-derived CMs thus correlates well with previous studies even
though previously reported data were conducted with transgenic or
non-human CMs.
In this study, low [K+]Ex prolonged the FPD and APD in all our
CMs (WT, LQT1A and LQT1B). This data is supported by previous
findings with various animal studies as well as in isolated
ventricular CMs (White and Terrar, 1991; Akita et al., 1998; Guo
et al., 2011; Pezhouman et al., 2015; Chan et al., 2015; Osadchii,
2010). The prolongation of repolarization in hypokalemia (low
[K+]Ex) has also been documented in cardiac patients receiving
diuretic therapy (Stewart et al., 1985). It is well established that low
[K+]Ex suppresses the K
+ currents such as IKr contributing to
delayed repolarization thereby prolonging the QT-interval (Yang
et al., 1997; Sanguinetti and Jurkiewicz, 1992; Scamps and
Carmeliet, 1989; Guo et al., 2011; Osadchii, 2010). Thus, low
extracellular K+ is recognized as a factor reducing the repolarization
reserve (Varró and Baczkó, 2011).
The repolarization phase involves primarily IKr and IKs in
ventricle myocytes. The LQT1 lines used in this study had mutation
in the KCNQ1 depressing the IKs current, which is presented as FPD
and APD prolongations at baseline. Thus, this suggests
prolongation in FPD and APD to increase in low [K+]ex partly
due to the lack of IKs repolarization reserve. The deficiency in IKs
current in our LQT1 lines reproduces our previous findings where
we show no or only a marginal effect on the APDs with a partial IKs
blockade (JNJ303) in the LQT1 lines but robust effects in the WT
line (Kiviaho et al., 2015). As expected, a partial IKr blockade
(E4031) resulted in a prolongation of FPD and APD in the WT,
LQT1A and LQT1B lines (Kiviaho et al., 2015; Pradhapan et al.,
2013).
In a transgene expression system with the G589D point mutation,
a reduced IKs current has been reported (Piippo et al., 2001). The
G589D mutation has been found to be a trafficking defect
(Aromolaran et al., 2014). The IVS7-2A>G splicing mutation is a
‘loss-of-function’ defect (Fodstad et al., 2006). Based on earlier
expression studies in co-expression with wild-type KCNQ1 and
KCNE1, the IVS7-2A>G mutation decreases IKs current more than
the G589D mutation (Piippo et al., 2001; Fodstad et al., 2006).
Thus, these earlier findings support our data with difference in
repolarization times, but do not explain the presence of EADs. This
Table 2. Action potential durations (APD) from single cardiomyocyte at baselines and low [K+]Ex
(A)
WT n APD10 (ms) APD50 (ms) APD90 (ms) APA (mV) MDP (mV)
Baseline 3 156.87±16.16 315.71±44.96 374.59±49.13 113.95±4.59 −73.17±4.43
3 mM K+ 182.92±32.57 358.03±51.02 417.14±57.39 117.68±5.71 −75.86±5.44
Baseline 11 133.40±10.94 313.06±27.64 366.45±31.62 112.51±2.29 −72.34±2.18
2 mM K+ 154.90±15.19** 394.86±39.46*** 455.36±43.58*** 118.18±2.81*** −75.70±2.60*
Baseline 17 142.54±6.36 313.44±17.67 363.8±19.08 114.22±1.35 −73.22±1.31
1 mM K+ 153.66±8.80* 397.79±26.01*** 459.05±28.09*** 119.29±1.50*** −76.58±1.30**
(B)
LQT1A n APD10 (ms) APD50 (ms) APD90 (ms) APA (mV) MDP (mV)
Baseline 13 165.38±11.80 495.43±47.59 578.58±52.55 115.50±1.43 −73.65±1.23
3 mM K+ 170.77±12.09* 542.88±52.58*** 639.32±61.88*** 117.72±1.26*** −75.31±1.14***
Baseline 10 166.03±10.33 465.03±38.07 543.74±44.79 115.82±1.62 −73.37±1.39
2 mM K+ 183.73±13.63* 562.11±48.62*** 665.67±61.48*** 120.73±1.91** −77.23±1.52**
Baseline 15 177.96±9.43 497.06±28.84 570.09±30.14 115.63±1.25 −74.04±1.02
1 mM K+ 177.90±11.05 625.26±42.56*** 734.66±45.90*** 119.08±1.40*** −76.73±1.10***
(C)
LQT1B n APD10 (ms) APD50 (ms) APD90 (ms) APA (mV) MDP (mV)
Baseline 10 169.39±14.10 420.44±31.93 484.33±35.44 112.67±2.26 −71.54±2.10
3 mM K+ 190.31±18.95* 487.19±38.42** 556.36±40.44** 115.34±2.68*** −73.63±2.40**
Baseline 8 153.72±14.54 406.09±33.07 473.80±37.36 111.29±2.65 −70.05±2.43
2 mM K+ 175.27±15.32*** 507.54±34.75*** 588.40±40.32*** 115.10±3.02*** −72.99±2.67*
Baseline 16 181.38±11.86 424.92±25.85 489.65±28.02 114.35±1.51 −72.75±1.38
1 mM K+ 219.11±17.97** 598.86±43.19*** 682.71±45.93*** 119.23±1.70*** −75.54±1.59**
(D)
K+ concentration n WT LQT1A LQT1B
3 mM 3/13/10 42.55±13.17 60.74±12.91 72.03±16.45
2 mM 11/10/8 88.91±16.52 121.93±20.77 114.60±10.59
1 mM 17/15/16 95.24±13.55 164.57±22.59* 193.06±23.79**
(A-C) APDs at baseline and low [K+]Ex obtained from action potentials recorded from (A)WT, (B) LQT1A and (C) LQT1B, respectively. (D) The absolute Δ increase
in the APD90 in milliseconds from baseline to its corresponding 3, 2 and 1 mM [K+]Ex. Statistical significance (A-C) was calculated by using paired t-test, and in
(D) it was calculated using ANOVA between the lines at each [K+]Ex *P<0.05, **P<0.01 and ***P<0.001. n=cardiomyocytes recorded for each data point. Data is
presented as mean±s.e.m.
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refers to complexity of K+ homeostasis and additional mechanisms
in CMs.
The baseline FPD and APD in our data demonstrate that the
repolarization time of LQT1A is longer than that of LQT1B, but
LQT1B is more sensitive to low [K+]Ex despite MDP and APA
being similar in LQT1A and LQT1B CMs. Since IKr is a major
player involved in repolarization, the simplest explanation would be
that the IKr contribution to the repolarization reserve pool is larger in
LQT1B than in LQT1A. The repolarization reserve pool of LQT1B
would thus show greater K+ sensitivity due to suppressed K+
conductance, increased electromotive force when acutely exposed
to low [K+]Ex (Zaza, 2009) and no IKs functionality. This would also
explain why LQT1B has shorter FPD and APD baseline values
compared to LQT1A in this study. Moreover, this would be in line
with our previous finding that EADs in LQT1B are more
pronounced compared to LQT1A during an IKr blockade with
E4031 at normal physiological K+ conditions (Kiviaho et al., 2015).
As IKs is diminished in our LQT1 lines, the IKr functionality will
become important for the repolarization reserve during development
of hypokalemia. The acute and chronic K+ homeostasis is complex
with effects in a variety of parameters. Based on our studies we can
exclude IKs as a major contributor in the repolarization reserve in
the LQT1 lines. This is supported by the fact that only LQT1A
CMs present a prolonged phase 2 triangularity and EADs, but not
LQT1B CMs which, however, have less IKs current based on gene
transfection experiments (Piippo et al., 2001; Fodstad et al., 2006).
Action potential shape has been suggested to play a crucial role in
occurrence of pro-arrhythmic events (Hondeghem et al., 2001;
Osadchii and Olesen, 2009). Phase 3 triangularity is shown to be a
marker for pro-arrhythmia in monophasic action potentials of
guinea pig and rabbit hearts (Hondeghem et al., 2001; Osadchii and
Olesen, 2009). IKr deficiency has also been associated in phase 3
triangularity (Hondeghem et al., 2001); however, in this study, we
did not find EADs evoked in phase 3 but in phase 2 suggesting a
reopening of L-type calcium channels (ICa,L), i.e. in the LQT1A
CMs with EADs, these repeatedly occurred between –15 mV and
–27 mV. It has previously been suggested that phase 2 EADs are
carried by ICa,L following an APD prolongation towards a more
negative membrane potential while we cannot exclude that the Na+/
Ca2+-exchanger works in concert with the ICa,L (Guo et al., 2007;
Sipido et al., 2007; Banyasz et al., 2012). It is currently unknown
what causes the further prolongation and triangularity in phase 2
giving rise to EADs found in our LQT1A CMs. It should be noted
that no arrhythmia was detected and no phase 2 triangularity was
observed in LQT1B and WT CMs.
Potential limitations of the study
The effects of low [K+]Ex on hiPSC-derived CM may not
completely reflect the symptoms of hypokalemia in vivo. hiPSC-
derived CMs are still more fetal-like and this has to be considered
when translating these results to the clinics. IKs and IKr have not been
quantified in our study but their functionality has been analyzed
with the use of specific ion channel blockers in our previous study
(Kiviaho et al., 2015). Further understanding the interaction
between ion channels and exchangers is needed for revealing the
underlying mechanisms of prolongation and arrhythmia observed
in the LQT1 lines used in this study. Here, we only have an acute
expose and long term exposure to low [K+]Ex on hiPSC-derived
CMs may reveal different characteristics.
Fig. 2. Representative current clamp recordings of spontaneous actions
potentials extracted fromsingle ventricular-like cardiomyocyte baselines
and their corresponding responses to 1 mM [K+]Ex and dose-dependent
prolongation of APD90 induced by [K+]Ex. (A-C) Representative baselines
(upper traces) and the corresponding effect of 1 mM [K+]Ex (lower traces) for
(A) WT, (B) LQT1A and (C) LQT1B, respectively. Scale bars: abscissa 40 mV
and ordinate 2 s. Dashed lines (A-C) indicate 0 mV.
Fig. 3. Representative current clamp recordings of arrhythmia in LQT1A
cardiomyocytes. (A) A cardiomyocyte without early afterdepolarization (EAD)
in baseline (upper trace) and with (EAD) only observed at 1 mM [K+]Ex (lower
trace). (B) Depicts a cardiomyocyte with EADs in baseline (upper trace) and
EADs were prolonged at 1 mM [K+]Ex (lower trace). Arrows point to the
beginning and end of the arrhythmic Phase 2. Scale bars: 40 mV in abscissa
and 2 s in ordinate. Dashed lines (A and B) indicate 0 mV. Note that EADswere
only found in LQT1A cardiomyocytes with more prolonged baseline APDs (see
Fig. 2B for a comparison).
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In conclusion, we have shown that low [K+]Ex delays the
repolarization in hiPSC-derived CMs at single cell as well as at
multicellular level. The LQT1 CMs are more sensitive to potassium
electrolyte disturbances than WT CMs, thus confirming previous
clinical studies. In LQT1 CMs with G589D mutation phase 2
triangularity in EADs were occasionally observed at baseline or
could be further evoked by low [K+]Ex. However, phase 2
triangularity or EADs could not be evoked in LQT1 CMs with
IVS7-2A>G mutation or in WT CMs. The effects of low [K+]Ex has
not previously been investigated in hiPSC-derived CMs. Thus, this
work demonstrates that the hiPSC-derived CMs provide a platform
for studying the effects of low extracellular K+ and also provide a
platform to study acquired LQTS.
MATERIAL AND METHODS
Ethical approval
The study was approved by the Ethics Committee of Pirkanmaa Hospital
District to establish, culture, and differentiate hiPSC lines (R08070).
Participants donating skin biopsies signed an informed consent after
receiving oral and written descriptions of the study. Skin biopsies for hiPSC
establishment were received from the Heart Hospital, Tampere University
Hospital, Tampere, Finland.
Long QT patient characteristics
The LQT patient characteristics have been previously described elsewhere
(Kiviaho et al., 2015). In brief, the LQT1 patient carrying G589D mutation
is a 46-year-old female with corrected QT interval (QTc) of 464 ms. The
other LQT1 patient carrying IVS7-2A>G is a 51-year-old female with QTc
value of 489 ms. These patients are symptomatic with episodes of syncope.
Human induced pluripotent stem cell generation and culture
Patient-specific hiPSCs were generated as described earlier (Takahashi
et al., 2007). The LQT1-specific hiPSCs were derived from patients carrying
G589D or IVS7-2A>G mutation in the KCNQ1 as previously described
(Kiviaho et al., 2015). Healthy control hiPSCs (WT) were derived from skin
fibroblasts of a healthy 55-year-old female (Ahola et al., 2014). hiPSC lines
were cultured in knockout serum replacement medium using mouse
embryonic fibroblasts (Millipore, Billerica, MA, USA) as feeders. The
following components were included in the knockout serum replacement
medium: knockout-DMEM (Invitrogen, Carlsbad, CA, USA) containing
20% knockout-serum replacement (Invitrogen, Carlsbad, CA, USA),
nonessential amino acids, GlutaMAX, penicillin/streptomycin, 0.1 mM 2-
mercaptoethanol and 4 ng/ml fibroblast growth factor 2 (R&D Systems Inc.,
Minneapolis, MN, USA). The mediumwas refreshed three times aweek and
the hiPSCs were passaged weekly using collagenase IV (Invitrogen,
Carlsbad, CA, USA).
Cell line characterizations and cardiomyocyte differentiation
The hiPSC lines and hiPSC-derived CMs used in this study have been
characterized elsewhere. The control cell line UTA.04602.WT (WT) andWT-
derived CMs have been characterized in detail previously (Ahola et al., 2014).
The hiPSC lines UTA.00208.LQT1 (LQT1A, derived from patient carrying
G589D mutation) and UTA.00118.LQT1 (LQT1B, derived from patient
carrying IVS7-2A>G mutation) and CMs derived from them have been
characterized (Kiviaho et al., 2015). The hiPSCs were differentiated into CMs
in co-culture with mouse visceral endoderm-like cells. The differentiation
method has been described elsewhere (Mummery et al., 2003).
Multielectrode array recordings and data analysis
hiPSC-derived CMs (30-35 days old) were used in this study. Spontaneously
beating CM clusters were manually dissected and plated on 6-well MEAs
(6-wellMEA 200/30iR-Ti-tcr,Multichannel Systems, Reutlingen, Germany),
which were first coated with fetal bovine serum (FBS, Invitrogen, Carlsbad,
CA, USA) for 30 min at room temperature and then with 0.1% gelatin (Sigma
Aldrich, St Louis, MO, USA) for 1 h at room temperature. The CM clusters
were plated in EB-medium consisting of: knockout-DMEM with 20% FBS,
nonessential amino acids, GlutaMAX and penicillin/streptomycin. Custom
madeK+ free DMEM (Irvine Scientific, CA, USA) supplementedwith varying
concentrations of K+ (B. Braun, Melsungen, Germany, KCl 150 mg/ml) and
penicillin/streptomycin were used in this study. The following [K+]Ex were
used: 5.33, 4, 3, 2 and 1 mM. The EB-medium was changed to serum-free
culture medium (5.33 mM K+) and after the incubation of 1 h, the field
potentials originating from the CMs were recorded (baseline). After baseline
recordings, the [K+]Ex in the medium was sequentially reduced from 4 mM to
1 mM by medium exchanges with 45 min incubations in between each
concentration and recorded at 37°C using MEAs (MEA1060-Inv-BC,
Multichannel Systems, Reutlingen, Germany) using 20 kHz sampling
frequency and MC_Rack software (Multichannel Systems, Reutlingen,
Germany). Note, 4 mM induced no or only marginal effects on FPD (data
not shown), thus it has not been included to the result section for clarity of the
presentation. The MEAs were covered with gas permeable membranes (ALA
MEA-Sheet, ALA Scientific, NY, USA) during the recordings. The total
recording time for each concentration was 2 min. The MEA data was analyzed
by in-house-developed CardioMDA software (Pradhapan et al., 2013).
CardioMDA is available from BioMediTech website (http://www.
biomeditech.fi/CardioMDA/). The Bazett’s and Fridericia’s formulae were
used to calculate the beat rate corrected FPD. The criteria for data analysis of the
MEA recordings was that only the aggregates responding to low [K+]Ex with
FPD prolongation were included in this study.
Current clamp
Current clamp recordings were performed as previously described (Kiviaho
et al., 2015). In brief, the perforated patch clamp technique was used with
amphotericin-B as perforation agent with a final concentration of 240 µg/ml
Table 3. Action potential characteristics of LQT1A cardiomyocytes exhibiting early afterderpolarizations
(A)
LQT1A n APD10 (ms) APD50 (ms) APD90 (ms) APA (mV) MDP (mV)
Baseline 5 286.89±59.09 1364.37±274.01 1524.56±286.56 121.89±2.72 −75.36±1.59
1 mM K+ EAD 295.81±70.51 2769.31±1124.54 3685.82±1493.54 121.86±4.42 −74.32±2.80
(B)
LQT1A n APD10 (ms) APD50 (ms) APD90 (ms) APA (mV) MDP (mV)
Baseline EAD 2 179.64±2.91 1023.49±117.23 2059.02±883.91 107.99±6.92 −65.48±5.68
3 mM K+ EAD 199.24±26.70 1194.39±365.80 3193.29±1781.73 110.62±4.13 −67.69±4.78
Baseline EAD 2 194.58±27.72 894.13±110.15 1170.46±242.60 116.66±2.39 −68.79±0.66
2 mM K+ EAD 205.33±36.64 1018.42±168.47 1637.03±572.69 116.21±1.32 −68.06±2.76
Baseline EAD 4 175.03±34.07 1048.61±98.32 1674.84±426.04 115.69±3.29 −69.45±2.07
1 mM K+ EAD 219.81±54.40 1822.10±270.95* 3088.91±709.53 121.05±3.55* −74.44±2.24*
(A) LQT1A cardiomyocytes without early after depolarization (EAD) at baseline but observed at 1 mM [K+]Ex with their respective action potential characteristics.
(B) LQT1A cardiomyocytes with EAD at baseline and low [K+]Ex, with their respective action potential characteristics. Statistical significance (A) and (B) was
calculated by using paired t-test, *P<0.05. n=cardiomyocytes recorded for each data point. Data is presented as mean±s.e.m.
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(Hamill et al., 1981; Rae et al., 1991). Action potentials were acquired with
an Axon Series 200B amplifier and a Digidata 1440 AD/DA converter
(Molecular device, LTD, USA). Dissociated CMs were plated on 5 mmØ
coverslips and recorded on the 6th or 7th day. In brief, coverslips were
transferred to a RC-24N recording chamber (Harvard Instruments UK,
Warner Instruments, USA) and placed on an inverted Olympus IX71
microscope. The perfusate was maintained at 35-36°C using an SH-27B
inline heater (Harvard Apparatus Ltd., Kent, UK). The HEPES based
extracellular solution (HBS) contained (in mM): 143 NaCl, 1.8 CaCl2,
1.2MgCl2, 5 glucose and 10 HEPES. For experiments KCl was added to the
HBS to final concentrations of 1, 2, 3 and 4.8 mM K+ (pH was set to 7.4
with NaOH and osmolarity set to 300-302 mOsm with sucrose). HBS with
4.8 mM K+ was used in baseline recordings. The pipette solution contained
(in mM): 122 KMeSO4, 30 KCl, 1.2MgCl2, 1 CaCl2 (pHwas set to 7.2 with
KOH and osmolarity set to 290-292mOsm with sucrose). The pipette
resistance was ∼3MΩ after filling with pipette solution. The action
potentials from spontaneously beating CMs were recorded in current clamp
mode. Current clamp recordings were digitally sampled at 20 kHz and
filtered at 2 kHz using low pass Bessel filter on recording amplifier. AP
duration at 10, 50 and 90% repolarization (APD10, APD50 and APD90),
APA, and MDP were extracted from recorded action potentials using in
house developed analysis modules running on the Origin 9 platform
(Microcal OriginTM, Northampton, Massachusetts, USA). Baseline data in a
CM was extracted from a minimum of 15 single APs and summed for
statistics. When EADs were present in a CM, a minimum of 5 single APs
were obtained in regions with maximal effect of [K+]Ex and summed for
each concentration for statistics. Acute application of [K+]Ex was tested in
sequential application without wash out, with wash out and with single
applications from baselines to either 3, 2 or 1 mM [K+]Ex. Maximal effect
was observed in seconds and recordings were fully reversible, thus data is
pools of these series. The data presented from current clamp was from
ventricular-like CMs. These were grouped as ventricular-like when baseline
APs had APD90/50 <1.3, APA >100 mV and MDP <−60 mV. The Phase 2
AP triangularity was calculated as APD50/10.
Statistical analyses
One-way ANOVA followed by Tukey’s post hoc test was used to assess
differences in means of groups of three pairs. Paired t-test was used to access
difference between the means in baseline and the corresponding effect of 3,
2 or 1 mMK+ in the same recording, while unpaired t-test was uses to access
differences in means of two similar recordings (Microcal Origin™ 9.1,
Northampton, Massachusetts, USA). Significant difference in the tables is
presented as *P<0.05, **P<0.01 and ***P<0.001 and data is presented as
mean±s.e.m.
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Hyttinen, J. (2014). Video image-based analysis of single human induced
pluripotent stem cell derived cardiomyocyte beating dynamics using digital image
correlation. Biomed. Eng. Online 13, 39.
Akita, M., Kuwahara, M., Tsubone, H. and Sugano, S. (1998). ECG changes
during furosemide-induced hypokalemia in the rat. J. Electrocardiol. 31, 45-49.
Aromolaran, A. S., Subramanyam, P., Chang, D. D., Kobertz, W. R. and
Colecraft, H. M. (2014). LQT1mutations in KCNQ1 C-terminus assembly domain
suppress IKs using different mechanisms. Cardiovasc. Res. 104, 501-511.
Banyasz, T., Horvath, B., Jian, Z., Izu, L. T. and Chen-Izu, Y. (2012). Profile of
L-type Ca(2+) current and Na(+)/Ca(2+) exchange current during cardiac action
potential in ventricular myocytes. Heart Rhythm. 9, 134-142.
Barhanin, J., Lesage, F., Guillemare, E., Fink, M., Lazdunski, M. and Romey, G.
(1996). K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac
potassium current. Nature 384, 78-80.
Bellin, M., Casini, S., Davis, R. P., D’Aniello, C., Haas, J., Ward-van Oostwaard,
D., Tertoolen, L. G. J., Jung, C. B., Elliott, D. A., Welling, A. et al. (2013).
Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in
long-QT syndrome. EMBO J. 32, 3161-3175.
Chan, Y.-H., Tsai, W.-C., Ko, J.-S., Yin, D., Chang, P.-C., Rubart, M., Weiss, J. N.,
Everett, T. H., Lin, S.-F. and Chen, P.-S. (2015). Small-conductance calcium-
activated potassium current is activated during hypokalemia and masks short-
term cardiac memory induced by ventricular pacing. Circulation 132, 1377-1386.
Egashira, T., Yuasa, S., Suzuki, T., Aizawa, Y., Yamakawa, H., Matsuhashi, T.,
Ohno, Y., Tohyama, S., Okata, S., Seki, T. et al. (2012). Disease characterization
using LQTS-specific induced pluripotent stem cells. Cardiovasc. Res. 95,
419-429.
Fodstad, H., Bendahhou, S., Rougier, J. S., Laitinen-Forsblom, P. J., Barhanin,
J., Abriel, H., Schild, L., Kontula, K. and Swan, H. (2006). Molecular
characterization of two founder mutations causing long QT syndrome and
identification of compound heterozygous patients. Ann. Med. 38, 294-304.
Gennari, F. J. (1998). Hypokalemia. New Engl. J. Med. 339, 451-458.
Guo, D., Zhao, X., Wu, Y., Liu, T., Kowey, P. R. and Yan, G.-X. (2007). L-type
calcium current reactivation contributes to arrhythmogenesis associated with
action potential triangulation. J. Cardiovasc. Electrophysiol. 18, 196-203.
Guo, J.,Wang, T., Yang, T., Xu, J., Li,W., Fridman, M. D., Fisher, J. T. and Zhang,
S. (2011). Interaction between the cardiac rapidly (I Kr) and slowly (I Ks) activating
delayed rectifier potassium channels revealed by low K +-induced herg endocytic
degradation. J. Biol. Chem. 286, 34664-34674.
Hamill, O. P., Marty, A., Neher, E., Sakmann, B. and Sigworth, F. J. (1981).
Improved patch-clamp techniques for high-resolution current recording from cells
and cell-free membrane patches. Pflugers Arch. 391, 85-100.
Hondeghem, L. M., Carlsson, L. and Duker, G. (2001). Instability and triangulation
of the action potential predict serious proarrhythmia, but action potential duration
prolongation is antiarrhythmic. Circulation 103, 2004-2013.
Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A.,
Feldman, O., Gepstein, A., Arbel, G., Hammerman, H. et al. (2011). Modelling
the long QT syndrome with induced pluripotent stem cells. Nature 471, 225-229.
Kishida, H., Surawicz, B. and Fu, L. T. (1979). Effects of K+ and K+-induced
polarization on (dV/dt)max, threshold potential, and membrane input resistance in
guinea pig and cat ventricular myocardium. Circ. Res. 44, 800-814.
Kiviaho, A. L., Ahola, A., Larsson, K., Penttinen, K., Swan, H., Pekkanen-
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